Larry Robbins (Trades, Portfolio), founder of Glenview Capital Management, seeks capital appreciation through deep fundamental research on stocks with high growth potential. During the second quarter, Robbins made big purchases in three separate company stocks: IMS Health Holdings Inc. (NYSE:IMS), Williams Holdings Inc. (NYSE:WMB) and Quintiles Transnational Holdings Inc. (NYSE:Q).
Robbins purchased 6,759,068 shares of IMS Health at an average price of $25.64 per share. This investment increased his portfolio by 1.21%. Previously, the CEO of Glenview Capital sold his 2.5 million-share position during the third quarter of 2015 when IMS Health averaged $30.70 per share. Continue Reading »